Discover how rare earth orthovanadate nanoparticles are revolutionizing cancer treatment by inhibiting Ehrlich carcinoma growth through innovative nanomedicine approaches.
Exploring how a novel vanillin derivative BVAN08 alters cell cycle gene expression in HepG2 liver cancer cells, potentially opening new cancer treatment avenues.
Discover how genomic science is transforming cancer treatment from one-size-fits-all to hyper-personalized medicine through mutation mapping, functional drug testing, and adaptive therapy.